Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $334.7500 (2.04%) ($320.0600 - $337.0309) on Wed. Oct. 15, 2014. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.72% (three month average) | | RSI | 38 | | Latest Price | $334.7500(2.04%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -1.5% a day on average for past five trading days. | | Weekly Trend | REGN declines -2.7% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
XLV(38%) XBI(37%) QQQ(31%) SPY(30%) XLK(28%) | | Factors Impacting REGN price | REGN will decline at least -0.86% in a week (0% probabilities).
VIXM(-13%) TLT(-6%) SHY(-3%) IGOV(-3%) UUP(-2%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.86% (StdDev 1.72%) | | Hourly BBV | 0 () | | Intraday Trend | 3.3% | | | | | |
|
| Resistance Level | $353.04 | | 5 Day Moving Average | $338.69(-1.16%) | | 10 Day Moving Average | $347.6(-3.7%) | | 20 Day Moving Average | $353.04(-5.18%) | | To recent high | -8.1% | | To recent low | 12.9% | | Market Cap | $35.493b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |